Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GH

Guardant Health Inc

Nov 07 • 04:00PM ET

96.72

+0.47 0.49 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS FLGT BIO SRPT MYGN NTRA CDNA TXG

| Held by: IWM VTI VB IWO VBK VXF ARKG SCHA CGGR VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.21	Insider Own	4.49%	Shs Outstand	125.01M	Perf Week	3.98%
Market Cap	12.19B	Forward P/E	-	EPS next Y	-2.74	Insider Trans	-8.77%	Shs Float	120.39M	Perf Month	48.21%
Enterprise Value	12.94B	PEG	-	EPS next Q	-0.77	Inst Own	99.53%	Short Float	6.87%	Perf Quarter	76.50%
Income	-398.79M	P/S	13.51	EPS this Y	13.42%	Inst Trans	2.63%	Short Ratio	2.95	Perf Half Y	131.83%
Sales	902.57M	P/B	-	EPS next Y	11.05%	ROA	-28.33%	Short Interest	8.27M	Perf YTD	216.60%
Book/sh	-2.84	P/C	21.02	EPS next 5Y	20.17%	ROE	-4584.47%	52W High	100.22 -3.49%	Perf Year	311.22%
Cash/sh	4.60	P/FCF	-	EPS past 3/5Y	3.89% -33.61%	ROIC	-42.18%	52W Low	28.20 243.02%	Perf 3Y	95.04%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.52% 28.08%	Gross Margin	63.76%	Volatility	7.07% 5.66%	Perf 5Y	-9.32%
Dividend TTM	-	EV/Sales	14.33	EPS Y/Y TTM	24.17%	Oper. Margin	-49.02%	ATR (14)	5.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	30.38%	Profit Margin	-44.18%	RSI (14)	77.62	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	15.15%	SMA20	24.65%	Beta	1.58	Target Price	97.18
Payout	-	Debt/Eq	-	Sales Q/Q	38.50%	SMA50	43.25%	Rel Volume	0.97	Prev Close	96.25
Employees	2021	LT Debt/Eq	-	Earnings	Oct 29 AMC	SMA200	86.70%	Avg Volume	2.81M	Price	96.72
IPO	Oct 04, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.28% 12.56%	Trades		Volume	2,733,723	Change	0.49%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$75
Sep-22-25	Resumed	Wells Fargo	Overweight	$72
Apr-10-25	Initiated	Mizuho	Outperform	$55
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99

Show Previous Ratings

Today 08:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Nov-06-25 06:35PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:05AM	New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response (Business Wire)
07:05AM	Cathie Wood Loads Up Pinterest After Sell-Off -- Dumps Shopify, Roku, and Robinhood (GuruFocus.com)
Nov-05-25 04:05PM	Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients (Business Wire)
12:26PM	Loading…
12:26PM	Why Guardant Health (GH) Shares Are Sliding Today (StockStory)
02:15AM	Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering (Business Wire)
02:15AM	Guardant Health Announces Pricing of Upsized Public Offering of Common Stock (Business Wire)
12:37AM	The Top 5 Analyst Questions From Guardant Health's Q3 Earnings Call (StockStory)
Nov-04-25 04:39PM	Guardant Health Announces Proposed Public Offering of Common Stock (Business Wire)
04:38PM	Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033 (Business Wire)
Oct-31-25 10:01AM	Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook (Insider Monkey)
05:45AM	Why Guardant Health Was Such an Investor Darling This Week (Motley Fool)
Oct-30-25 07:19PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +27.87%
06:56PM	Why Guardant Health Stock Surged Today (Motley Fool)
04:13PM	Loading…
04:13PM	Why IBD 50's Guardant Health, Up 137% in 2025, Just Rocketed Again (Investor's Business Daily)
09:54AM	These Stocks Are Moving the Most Today: Microsoft, Meta, Alphabet, Chipotle, Carvana, FMC, Roblox, Guardant Health, Metsera, and More (Barrons.com)
09:11AM	GH Q3 Deep Dive: Broad-Based Growth, Screening Momentum, and Margin Improvement (StockStory)
Oct-29-25 07:30PM	Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:05PM	Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
05:18PM	Guardant Health's (NASDAQ:GH) Q3: Strong Sales, Stock Jumps 15.5% (StockStory)
05:03PM	Guardant Health: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (Business Wire)
Oct-27-25 11:10PM	Earnings To Watch: Guardant Health (GH) Reports Q3 Results Tomorrow (StockStory)
09:20AM	Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals (Zacks)
08:05AM	Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights (Business Wire)
Oct-26-25 03:01PM	Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025 (Business Wire)
Oct-21-25 03:41PM	Colon Cancer Screening Leader Guardant Health Tests Buy Point As Earnings Loom (Investor's Business Daily)
Oct-20-25 04:24PM	Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 231% In A Month (Investor's Business Daily) +7.24%
Oct-18-25 08:00AM	S&P 500's Walmart In Buy Zone, Leads Five Stocks Near Buy Points (Investor's Business Daily)
08:00AM	Loading…
08:00AM	S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile Market (Investor's Business Daily)
04:16AM	Grail Blood Test Found Seven Times More Cancers Than Standard Tests, Data Show (Barrons.com)
Oct-17-25 09:45AM	Tempus AI Fuels Growth Through Strategic Biotech Collaborations (Zacks)
09:35AM	Banks Look To Stabilize After First Brands Bankruptcy Torpedoes Shares (Investor's Business Daily)
08:17AM	Stock Market Today: Dow Falls Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
Oct-15-25 04:57PM	Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025 (Business Wire) +5.11%
Oct-09-25 04:05PM	Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 (Business Wire)
Sep-30-25 12:33PM	Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy (Insider Monkey)
09:05AM	DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute (Zacks)
Sep-29-25 12:15PM	Why Guardant Health (GH) Stock Is Trading Up Today (StockStory)
08:05AM	FDA Approves Guardant360 CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer (Business Wire)
Sep-26-25 11:25AM	Guardants New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases. (Barrons.com)
Sep-25-25 02:24PM	Guardant's New Blood Test Can Detect Many Different Cancers. It's Promising the Same for Other Diseases. (Barrons.com)
12:41PM	Guardant Health (GH) Stock Trades Up, Here Is Why (StockStory)
09:00AM	Wolfe Research lifts Guardant Health to Outperform, sees 30% upside (Investing.com)
Sep-24-25 08:05AM	Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield Blood-based Screening Test in the United States (Business Wire)
12:00AM	3 Reasons to Avoid GH and 1 Stock to Buy Instead (StockStory)
Sep-23-25 03:26PM	Guardant Health (GH) Stock Is Up, What You Need To Know (StockStory)
Sep-22-25 09:35AM	Humana initiated, Paycom upgraded: Wall Street's top analyst calls (The Fly)
Sep-18-25 11:31PM	Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz (StockStory)
Sep-17-25 11:33PM	Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks (StockStory)
Sep-15-25 04:07PM	Alex M. Azar II Joins Guardant Health Board of Directors (Business Wire)
Sep-11-25 05:33PM	More Blood Tests for Cancer Hit the Market (Barrons.com)
08:05AM	Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership (Business Wire)
Sep-10-25 07:03PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Sep-08-25 08:05AM	Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States (Business Wire)
Sep-05-25 05:28AM	Guardant Health reports positive clinical readout update for Shield algorithm (Medical Device Network)
Sep-04-25 12:30PM	What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? (Zacks) -5.69%
12:16PM	Why Guardant Health (GH) Shares Are Plunging Today (StockStory)
12:16PM	Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run (Investor's Business Daily)
08:06AM	Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test (Business Wire)
Sep-02-25 09:30AM	Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands (PR Newswire)
Aug-28-25 04:05PM	Guardant Health to Host Investor Day on September 24, 2025 (Business Wire)
Aug-26-25 04:05PM	Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (Business Wire)
Aug-15-25 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
09:15AM	TMO Receives FDA Approval for Oncomine Dx Target Test (Zacks)
Aug-14-25 06:50PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Aug-13-25 08:37AM	TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? (Zacks) +6.30%
Aug-12-25 11:56PM	The 5 Most Interesting Analyst Questions From Guardant Health's Q2 Earnings Call (StockStory)
11:49PM	GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges (StockStory)
Aug-11-25 09:06AM	Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 (GlobeNewswire)
Aug-04-25 08:06AM	American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity (Business Wire) +6.69%
Aug-01-25 09:00AM	BioMarin Announces Appointment of Ian T. Clark to Board of Directors (PR Newswire)
Jul-31-25 04:05PM	Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire) -9.32%
11:26AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
03:33AM	Guardant Health Inc (GH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
Jul-30-25 07:00PM	Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:36PM	Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales (StockStory)
06:00PM	Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:57PM	Guardant Health: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (Business Wire)
08:09AM	Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ (Business Wire)
Jul-29-25 08:43AM	Tempus AI Taps Growing ICI Market With New xM Assay (Zacks)
08:07AM	New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer (Business Wire)
Jul-28-25 11:08PM	Guardant Health (GH) Q2 Earnings: What To Expect (StockStory)
Jul-24-25 06:26AM	Cathie Wood's Bold AI and Genomics Playbooks Revealed (GuruFocus.com)
06:22AM	Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab (GuruFocus.com)
Jul-23-25 12:05AM	3 Reasons to Avoid GH and 1 Stock to Buy Instead (StockStory)
Jul-15-25 11:01AM	First Patient Enrolled in National Cancer Institute's Vanguard Study Evaluating Guardant Health's Shield Multi-Cancer Detection Test (Business Wire)
Jul-14-25 08:00AM	Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 (Business Wire)
Jul-11-25 03:31PM	Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know (StockStory)
Jul-04-25 08:43AM	Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release (Zacks)
Jun-30-25 07:26AM	The 5 Most Interesting Analyst Questions From Guardant Health's Q1 Earnings Call (StockStory)
Jun-25-25 08:51AM	The Top 5 Analyst Questions From Guardant Health's Q1 Earnings Call (StockStory)
Jun-23-25 03:00PM	TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now? (Zacks)
12:07PM	Medical Services Name Flirts With A Buy Point (Investor's Business Daily)
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 05:54PM	How Will Dow Jones Futures Open As Trump Says 'Two Weeks' For Iran Decision? (Investor's Business Daily)
03:35PM	Will Dow Jones Futures Rebound As Trump Says 'Two Weeks' For Iran Decision? (Investor's Business Daily)
Jun-13-25 12:35AM	3 of Wall Street's Favorite Stocks Facing Headwinds (StockStory)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hidalgo Medina Manuel	Director	Nov 07 '25	Proposed Sale	95.19	1,500	142,780		Nov 07 04:25 PM
Saia John G.	Officer	Nov 07 '25	Proposed Sale	96.25	8,996	865,865		Nov 07 04:21 PM
Krognes Steve E.	Director	Oct 31 '25	Option Exercise	0.00	154	0	18,436	Nov 03 05:45 PM
MIGNONE ROBERTO	Director	Oct 21 '25	Option Exercise	0.00	3,167	0	3,167	Oct 22 07:07 PM
Hidalgo Medina Manuel	Director	Oct 17 '25	Option Exercise	0.00	232	0	1,315	Oct 20 07:50 PM
Tariq Musa	Director	Oct 17 '25	Sale	66.95	116	7,766	7,725	Oct 20 07:49 PM
POTTER MYRTLE S	Director	Oct 17 '25	Sale	66.95	26	1,741	18,324	Oct 20 07:48 PM
Tariq Musa	Director	Oct 17 '25	Proposed Sale	66.95	116	7,766		Oct 17 04:02 PM
POTTER MYRTLE S	Director	Oct 17 '25	Proposed Sale	66.96	26	1,741		Oct 17 04:00 PM
Tariq Musa	Director	Oct 15 '25	Option Exercise	0.00	250	0	7,841	Oct 16 09:13 PM
POTTER MYRTLE S	Director	Oct 15 '25	Option Exercise	0.00	69	0	18,350	Oct 16 09:11 PM
Saia John G.	Chief Legal Officer	Oct 01 '25	Option Exercise	0.00	14,167	0	59,599	Oct 02 08:06 PM
Monroe Terilyn J.	Chief People Officer	Oct 01 '25	Option Exercise	0.00	10,477	0	31,397	Oct 02 08:05 PM
Kalia Kumud	Chief Information Officer	Oct 01 '25	Option Exercise	0.00	10,549	0	29,713	Oct 02 08:05 PM
Freeman Chris	Chief Commercial Officer	Oct 01 '25	Option Exercise	0.00	13,550	0	63,179	Oct 02 08:05 PM
EAGLE CRAIG	Chief Medical Officer	Oct 01 '25	Option Exercise	0.00	13,859	0	51,341	Oct 02 08:04 PM
Chudova Darya	Chief Technology Officer	Oct 01 '25	Option Exercise	0.00	16,104	0	97,553	Oct 02 08:04 PM
Bell Michael Brian	Chief Financial Officer	Oct 01 '25	Option Exercise	0.00	15,181	0	59,822	Oct 02 08:04 PM
Talasaz AmirAli	Co-Chief Executive Officer	Sep 30 '25	Option Exercise	0.00	4,814	0	1,988,479	Oct 02 08:03 PM
Talasaz AmirAli	Co-Chief Executive Officer	Oct 01 '25	Option Exercise	0.00	23,997	0	2,010,036	Oct 02 08:03 PM
Krognes Steve E.	Director	Sep 30 '25	Option Exercise	0.00	154	0	18,282	Oct 02 08:03 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Sep 30 '25	Option Exercise	0.00	4,814	0	2,128,313	Oct 02 08:01 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Oct 01 '25	Option Exercise	0.00	23,997	0	2,149,870	Oct 02 08:01 PM
Hidalgo Medina Manuel	Director	Sep 17 '25	Option Exercise	0.00	232	0	1,083	Sep 18 04:33 PM
Tariq Musa	Director	Sep 15 '25	Option Exercise	0.00	249	0	7,707	Sep 17 05:17 PM
Tariq Musa	Director	Sep 17 '25	Sale	55.63	116	6,453	7,591	Sep 17 05:17 PM
POTTER MYRTLE S	Director	Sep 15 '25	Option Exercise	0.00	68	0	18,307	Sep 17 05:17 PM
POTTER MYRTLE S	Director	Sep 17 '25	Sale	55.63	26	1,446	18,281	Sep 17 05:17 PM
Saia John G.	Chief Legal Officer	Sep 15 '25	Option Exercise	0.00	1,019	0	45,967	Sep 17 05:16 PM
Kalia Kumud	Chief Information Officer	Sep 15 '25	Option Exercise	0.00	638	0	19,488	Sep 17 05:15 PM
Freeman Chris	Chief Commercial Officer	Sep 15 '25	Option Exercise	0.00	1,402	0	50,223	Sep 17 05:15 PM
EAGLE CRAIG	Chief Medical Officer	Sep 15 '25	Option Exercise	0.00	1,402	0	38,193	Sep 17 05:14 PM
Bell Michael Brian	Chief Financial Officer	Sep 15 '25	Option Exercise	0.00	3,272	0	46,300	Sep 17 05:13 PM
POTTER MYRTLE S	Director	Sep 17 '25	Proposed Sale	55.62	26	1,446		Sep 17 04:17 PM
Tariq Musa	Director	Sep 17 '25	Proposed Sale	55.63	116	6,453		Sep 17 04:16 PM
Hidalgo Medina Manuel	Director	Sep 12 '25	Sale	54.16	2,165	117,251	851	Sep 15 05:09 PM
Hidalgo Medina Manuel	Director	Sep 12 '25	Proposed Sale	54.16	2,165	117,251		Sep 12 04:25 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Sep 09 '25	Sale	59.45	300,000	17,835,995	2,123,499	Sep 11 07:14 PM
Eltoukhy Helmy	Officer	Sep 09 '25	Proposed Sale	59.45	300,000	17,835,990		Sep 09 05:32 PM
Joyce Meghan V.	Director	Sep 02 '25	Sale	65.84	100	6,584	11,183	Sep 03 06:50 PM
Saia John G.	Chief Legal Officer	Sep 01 '25	Option Exercise	0.00	264	0	45,087	Sep 03 06:47 PM
Kalia Kumud	Chief Information Officer	Sep 01 '25	Option Exercise	0.00	711	0	19,211	Sep 03 06:46 PM
Chudova Darya	Chief Technology Officer	Sep 01 '25	Option Exercise	0.00	316	0	81,610	Sep 03 06:44 PM
Krognes Steve E.	Director	Aug 31 '25	Option Exercise	0.00	155	0	18,128	Sep 03 06:43 PM
Joyce Meghan V.	Director	Sep 02 '25	Proposed Sale	65.84	100	6,584		Sep 02 04:04 PM
Kalia Kumud	Chief Information Officer	Aug 21 '25	Sale	61.76	2,000	123,510	18,500	Aug 22 04:58 PM
Kalia Kumud	Officer	Aug 21 '25	Proposed Sale	61.76	2,000	123,510		Aug 21 04:19 PM
Tariq Musa	Director	Aug 19 '25	Sale	59.02	116	6,846	7,458	Aug 20 07:53 PM
POTTER MYRTLE S	Director	Aug 19 '25	Sale	59.02	26	1,535	18,239	Aug 20 07:51 PM
Tariq Musa	Director	Aug 19 '25	Proposed Sale	59.02	116	6,846		Aug 19 04:36 PM
POTTER MYRTLE S	Director	Aug 19 '25	Proposed Sale	59.02	26	1,535		Aug 19 04:35 PM
Hidalgo Medina Manuel	Director	Aug 17 '25	Option Exercise	0.00	232	0	3,016	Aug 18 05:44 PM
Tariq Musa	Director	Aug 15 '25	Option Exercise	0.00	250	0	7,574	Aug 18 05:43 PM
POTTER MYRTLE S	Director	Aug 15 '25	Option Exercise	0.00	69	0	18,265	Aug 18 05:41 PM
Joyce Meghan V.	Director	Aug 04 '25	Option Exercise	0.00	67	0	11,283	Aug 06 04:57 PM
Krognes Steve E.	Director	Jul 31 '25	Option Exercise	0.00	154	0	17,973	Aug 04 07:13 PM
Tariq Musa	Director	Jul 17 '25	Sale	48.20	116	5,591	7,324	Jul 18 05:25 PM
POTTER MYRTLE S	Director	Jul 17 '25	Sale	48.20	26	1,253	18,196	Jul 18 05:24 PM
Hidalgo Medina Manuel	Director	Jul 17 '25	Option Exercise	0.00	2,784	0	2,784	Jul 18 05:22 PM
Tariq Musa	Director	Jul 17 '25	Proposed Sale	48.20	116	5,591		Jul 17 04:39 PM
POTTER MYRTLE S	Director	Jul 17 '25	Proposed Sale	48.19	26	1,253		Jul 17 04:35 PM
Tariq Musa	Director	Jul 15 '25	Option Exercise	0.00	250	0	7,440	Jul 16 05:11 PM
POTTER MYRTLE S	Director	Jul 15 '25	Option Exercise	0.00	68	0	18,222	Jul 16 05:10 PM
Joyce Meghan V.	Director	Jul 04 '25	Option Exercise	0.00	66	0	11,216	Jul 07 04:44 PM
Saia John G.	Chief Legal Officer	Jul 01 '25	Option Exercise	0.00	2,641	0	46,209	Jul 02 09:26 PM
Kalia Kumud	Chief Information Officer	Jul 01 '25	Option Exercise	0.00	2,691	0	21,865	Jul 02 09:25 PM
Freeman Chris	Chief Commercial Officer	Jul 01 '25	Option Exercise	0.00	3,596	0	50,353	Jul 02 09:24 PM
EAGLE CRAIG	Chief Medical Officer	Jul 01 '25	Option Exercise	0.00	3,381	0	38,505	Jul 02 09:22 PM
Chudova Darya	Chief Technology Officer	Jul 01 '25	Option Exercise	0.00	3,007	0	82,819	Jul 02 09:21 PM
Bell Michael Brian	Chief Financial Officer	Jul 01 '25	Option Exercise	0.00	2,084	0	44,085	Jul 02 09:20 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 30 '25	Option Exercise	0.00	4,815	0	2,074,271	Jul 02 09:18 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	23,997	0	1,995,827	Jul 02 09:18 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jul 01 '25	Sale	50.88	100,000	5,087,630	1,971,830	Jul 02 09:18 PM
Krognes Steve E.	Director	Jun 30 '25	Option Exercise	0.00	154	0	17,819	Jul 02 09:17 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 30 '25	Option Exercise	0.00	4,815	0	2,414,105	Jul 02 09:16 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	23,997	0	2,435,661	Jul 02 09:16 PM
Tariq Musa	Director	Jun 18 '25	Sale	49.47	3,213	158,947	7,190	Jun 20 05:42 PM
POTTER MYRTLE S	Director	Jun 18 '25	Sale	49.47	26	1,286	18,154	Jun 20 05:40 PM
CLARK IAN T	Director	Jun 17 '25	Sale	48.38	6,672	322,819	9,851	Jun 20 05:26 PM
POTTER MYRTLE S	Director	Jun 18 '25	Proposed Sale	49.46	26	1,286		Jun 18 05:00 PM
Tariq Musa	Director	Jun 18 '25	Proposed Sale	49.47	3,213	158,947		Jun 18 04:43 PM
CLARK IAN T	Director	Jun 17 '25	Proposed Sale	48.38	6,672	322,818		Jun 17 04:01 PM
Saia John G.	Chief Legal Officer	Jun 15 '25	Option Exercise	0.00	1,020	0	44,103	Jun 16 08:05 PM
Kalia Kumud	Chief Information Officer	Jun 15 '25	Option Exercise	0.00	637	0	19,402	Jun 16 08:04 PM
Freeman Chris	Chief Commercial Officer	Jun 15 '25	Option Exercise	0.00	6,281	0	49,432	Jun 16 08:03 PM
EAGLE CRAIG	Chief Medical Officer	Jun 15 '25	Option Exercise	0.00	1,402	0	35,835	Jun 16 08:01 PM
Bell Michael Brian	Chief Financial Officer	Jun 15 '25	Option Exercise	0.00	3,272	0	43,660	Jun 16 07:59 PM
POTTER MYRTLE S	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	20,737	Jun 16 07:28 PM
POTTER MYRTLE S	Director	Jun 15 '25	Option Exercise	0.00	69	0	20,806	Jun 16 07:28 PM
POTTER MYRTLE S	Director	Jun 16 '25	Sale	49.70	2,626	130,512	18,180	Jun 16 07:28 PM
Joyce Meghan V.	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	14,487	Jun 16 07:27 PM
Joyce Meghan V.	Director	Jun 13 '25	Sale	47.22	3,337	157,573	11,150	Jun 16 07:27 PM
Tariq Musa	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	10,153	Jun 16 07:25 PM
Tariq Musa	Director	Jun 15 '25	Option Exercise	0.00	250	0	10,403	Jun 16 07:25 PM
Krognes Steve E.	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	17,665	Jun 16 07:24 PM
Gadde Vijaya	Director	Jun 12 '25	Option Exercise	0.00	6,674	0	24,314	Jun 16 07:23 PM
CLARK IAN T	Director	Jun 12 '25	Option Exercise	0.00	8,088	0	16,523	Jun 16 07:21 PM
POTTER MYRTLE S	Director	Jun 16 '25	Proposed Sale	49.70	2,626	130,512		Jun 16 04:20 PM
Joyce Meghan V.	Director	Jun 13 '25	Proposed Sale	47.22	3,337	157,573		Jun 13 04:03 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 09 '25	Sale	50.09	77,853	3,899,937	2,069,456	Jun 09 09:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience